The FDA just approved daraxonrasib, a breakthrough drug for advanced pancreatic cancer that doubles survival time. This is huge: pancreatic cancer was once thought untreatable. The researchers received a standing ovation when they presented the trial results, unheard of at scientific conferences. https://www.nytimes.com/2026/08/26/science/pancreatic-cancer-daraxonrasib-approval.html?unlocked_article_code=1.8VA.zmju.W-VPal8m1Jnu&smid=url-share